|
|
||||||||
Ann Thorac Surg 2002;74:665-670
© 2002 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
b Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
c Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
Accepted for publication April 21, 2002.
* Address reprint requests to Dr Kon, Department of Cardiothoracic Surgery, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, USA
e-mail: nkon{at}wfubmc.edu
Background. The Omniscience mechanical valve has been the subject of multiple clinical investigations with variable results, including reports of high complication and reoperation rates.
Methods. Records of all patients who received Omniscience valves were reviewed, and follow-up interviews were conducted to determine the incidence of valve-related morbidity, mortality, and functional results. Incidence of complications was expressed as events per 100 patient-years follow-up. Survival and freedom from valve-related complications and mortality were calculated using a product limit method.
Results. Between 1984 and 1988, 192 patients received 213 Omniscience valves [93 mitral (M), 79 aortic (A), and 20 multiple (D) valve replacements]. Perioperative mortality was 9%. The incidence of major valve-related morbidity was as follows: thrombosis, 1.30 M, 0.17 A, 0.72 D; endocarditis, 0.48 M, 0.18 A, 0 D; hemorrhagic, 4.67 M, 2.84 A, 5.00 D; embolic, 2.90 M, 2.27 A, 1.57 D; nonstructural dysfunction, 1.66 M, 1.08 A, 2.27 D; reoperation, 4.02 M, 1.99 A, 6.48 D. All explanted valves (n = 43) were examined, and 40% (n = 17) were found to have limited disc excursion in the absence of thrombus. Freedom from valve-related morbidity, mortality, or reoperation at 10 years was 22% for mitral, 39% for aortic, and 17% for multivalve replacements. At follow-up, only 73% of patients were New York Heart Association class I or II. Five- and 10-year estimated survivals were 72% and 55% for M, 80% and 51% for A, and 65% and 50% for D replacements.
Conclusions. Use of the Omniscience valve provided poor functional improvement and a significant incidence of valve-related complications, including the need for reoperation.
This article has been cited by other articles:
![]() |
A. A. Mikhail Unusual omniscience valve results Ann. Thorac. Surg., November 1, 2003; 76(5): 1774 - 1774. [Full Text] [PDF] |
||||
![]() |
M. S. Edwards, G. B. Russell, A. F. Edwards, J. W. Hammon Jr, A. R. Cordell, and N. D. Kon Unusual omniscience valve results: Reply Ann. Thorac. Surg., November 1, 2003; 76(5): 1774 - 1774. [Full Text] [PDF] |
||||
![]() |
Y. Misawa Pannus formation after mitral valve replacement with the omniscience prosthesis: letter 1 Ann. Thorac. Surg., August 1, 2003; 76(2): 658 - 658. [Full Text] [PDF] |
||||
![]() |
J. Teijeira Omniscience valve results: letter 2 Ann. Thorac. Surg., August 1, 2003; 76(2): 659 - 659. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |